Joe Mara | Vice President, Investor Relations |
Michel Vounatsos | Chief Executive Officer |
Alfred Sandrock, Jr. | Executive Vice President, Research & Development and Chief Medical Officer |
Jeffrey Capello | Executive Vice President and Chief Financial Officer |
Cory Kasimov | JPMorgan |
Geoff Meacham | Bank of America |
Umer Raffat | Evercore |
Marc Goodman | SVB Leerink |
Jay Olson | Oppenheimer |
Michael Yee | Jefferies |
Terence Flynn | Goldman Sachs |
Matthew Harrison | Morgan Stanley |
Ronny Gal | Bernstein |
Phil Nadeau | Cowen and Company |
Tim Anderson | Wolfe Research |
Brian Abrahams | RBC Capital |
Evan Seigerman | Credit Suisse |
Robyn Karnauskas | SunTrust Robinson Humphrey |
Good morning. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Second Quarter 2020 Financial Results and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers remarks there will be a question-and-answer session.